Artykuły w czasopismach na temat „P-PBPK model”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „P-PBPK model”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Mi, Kun, Shanju Pu, Yixuan Hou, Lei Sun, Kaixiang Zhou, Wenjin Ma, Xiangyue Xu i in. "Optimization and Validation of Dosage Regimen for Ceftiofur against Pasteurella multocida in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model". International Journal of Molecular Sciences 23, nr 7 (28.03.2022): 3722. http://dx.doi.org/10.3390/ijms23073722.
Pełny tekst źródłaJeong, Yoo-Seong, Min-Soo Kim, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung i Kyeong-Ryoon Lee. "Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans". Pharmaceutics 13, nr 6 (29.05.2021): 813. http://dx.doi.org/10.3390/pharmaceutics13060813.
Pełny tekst źródłaDallmann, A., P. Mian, P. Annaert, M. Pfister, K. Allegaert i J. van den Anker. "P21 PBPK modeling in pregnancy: achievements, shortcomings and future perspectives". Archives of Disease in Childhood 104, nr 6 (17.05.2019): e25.2-e25. http://dx.doi.org/10.1136/archdischild-2019-esdppp.59.
Pełny tekst źródłaNauwelaerts, Nina, Julia Macente, Neel Deferm, Rodolfo Hernandes Bonan, Miao-Chan Huang, Martje Van Neste, David Bibi i in. "Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project". Pharmaceutics 15, nr 5 (11.05.2023): 1469. http://dx.doi.org/10.3390/pharmaceutics15051469.
Pełny tekst źródłaKovar, Lukas, Christina Schräpel, Dominik Selzer, Yvonne Kohl, Robert Bals, Matthias Schwab i Thorsten Lehr. "Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates". Pharmaceutics 12, nr 6 (23.06.2020): 578. http://dx.doi.org/10.3390/pharmaceutics12060578.
Pełny tekst źródłaPilla Reddy, Venkatesh, Adrian J. Fretland, Diansong Zhou, Shringi Sharma, Buyun Chen, Karthick Vishwanathan, Dermot F. McGinnity, Yan Xu i Joseph A. Ware. "Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors". Cancer Chemotherapy and Pharmacology 88, nr 3 (2.06.2021): 451–64. http://dx.doi.org/10.1007/s00280-021-04302-5.
Pełny tekst źródłaYang, Yiting, Ping Li, Zexin Zhang, Zhongjian Wang, Li Liu i Xiaodong Liu. "Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes". International Journal of Molecular Sciences 21, nr 19 (24.09.2020): 7023. http://dx.doi.org/10.3390/ijms21197023.
Pełny tekst źródłaWills, Kenneth H., Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk i Andrew Rowland. "Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure". Pharmaceutics 14, nr 1 (27.12.2021): 47. http://dx.doi.org/10.3390/pharmaceutics14010047.
Pełny tekst źródłaKim, Min-Soo, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung i Kyeong-Ryoon Lee. "Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans". Pharmaceuticals 15, nr 6 (3.06.2022): 709. http://dx.doi.org/10.3390/ph15060709.
Pełny tekst źródłaBachelet, Delphine, Marc-André Verner, Monica Neri, Émilie Cordina Duverger, Corinne Charlier, Patrick Arveux, Sami Haddad i Pascal Guénel. "Breast Cancer and Exposure to Organochlorines in the CECILE Study: Associations with Plasma Levels Measured at the Time of Diagnosis and Estimated during Adolescence". International Journal of Environmental Research and Public Health 16, nr 2 (18.01.2019): 271. http://dx.doi.org/10.3390/ijerph16020271.
Pełny tekst źródłaBerghausen, Joerg, Frank Hans Seiler, Nathalie Gobeau i Bernard Faller. "Simulated rat intestinal fluid improves oral exposure prediction for poorly soluble compounds over a wide dose range". ADMET & DMPK 4, nr 1 (30.03.2016): 35. http://dx.doi.org/10.5599/admet.4.1.258.
Pełny tekst źródłaLiu, Rongrui, Tim R. Zacharewski, Rory B. Conolly i Qiang Zhang. "A Physiologically Based Pharmacokinetic (PBPK) Modeling Framework for Mixtures of Dioxin-like Compounds". Toxics 10, nr 11 (17.11.2022): 700. http://dx.doi.org/10.3390/toxics10110700.
Pełny tekst źródłaCiffroy, Philippe, T. Tanaka, E. Johansson i C. Brochot. "Linking fate model in freshwater and PBPK model to assess human internal dosimetry of B(a)P associated with drinking water". Environmental Geochemistry and Health 33, nr 4 (2.04.2011): 371–87. http://dx.doi.org/10.1007/s10653-011-9382-6.
Pełny tekst źródłaGaohua, Lu, Khaled Abduljalil, Masoud Jamei, Trevor N. Johnson i Amin Rostami-Hodjegan. "A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4". British Journal of Clinical Pharmacology 74, nr 5 (9.10.2012): 873–85. http://dx.doi.org/10.1111/j.1365-2125.2012.04363.x.
Pełny tekst źródłaTempleton, Ian E., Terry Podoll, Cecile Marie Krejsa i J. Greg Slatter. "A Mechanistic Physiologically Based Pharmacokinetic (PBPK) Drug Interaction Model for the Mouse Double Minute 2 (MDM2) Inhibitor KRT-232". Blood 136, Supplement 1 (5.11.2020): 9–10. http://dx.doi.org/10.1182/blood-2020-135987.
Pełny tekst źródłaSmith, Jordan N., Kari A. Gaither i Paritosh Pande. "Competitive Metabolism of Polycyclic Aromatic Hydrocarbons (PAHs): An Assessment Using In Vitro Metabolism and Physiologically Based Pharmacokinetic (PBPK) Modeling". International Journal of Environmental Research and Public Health 19, nr 14 (6.07.2022): 8266. http://dx.doi.org/10.3390/ijerph19148266.
Pełny tekst źródłaRusso, Francesca M., Felix De Bie, Ryan Hodges, Alan Flake i Jan Deprest. "Sildenafil for Antenatal Treatment of Congenital Diaphragmatic Hernia: From Bench to Bedside". Current Pharmaceutical Design 25, nr 5 (3.06.2019): 601–8. http://dx.doi.org/10.2174/1381612825666190320151856.
Pełny tekst źródłaKato, Takafumi, Tsuyoshi Mikkaichi, Yasushi Yoshigae, Noriko Okudaira, Takako Shimizu, Takashi Izumi, Shuichi Ando i Yoshiaki Matsumoto. "Quantitative analysis of an impact of P-glycoprotein on edoxaban's disposition using a human physiologically based pharmacokinetic (PBPK) model". International Journal of Pharmaceutics 597 (marzec 2021): 120349. http://dx.doi.org/10.1016/j.ijpharm.2021.120349.
Pełny tekst źródłaVerscheijden, Laurens F. M., Jan B. Koenderink, Saskia N. de Wildt i Frans G. M. Russel. "Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling". Archives of Toxicology 95, nr 9 (15.07.2021): 3015–29. http://dx.doi.org/10.1007/s00204-021-03115-y.
Pełny tekst źródłaNguyen, Dung N., Xiusheng Miao, Mindy Magee, Guoying Tai, Peter D. Gorycki i Katy P. Moore. "1315. No Dose Adjustment of Metformin with Fostemsavir Coadministration Based on Mechanistic Static and Physiologically Based Pharmacokinetic Models". Open Forum Infectious Diseases 7, Supplement_1 (1.10.2020): S669. http://dx.doi.org/10.1093/ofid/ofaa439.1497.
Pełny tekst źródłaLiu, Jian, Swan Lin, Anthony Huynh i Weiwei Tan. "Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib". Pharmaceutics 16, nr 1 (17.01.2024): 118. http://dx.doi.org/10.3390/pharmaceutics16010118.
Pełny tekst źródłaDesai, Amit, Laura Kovanda, Christopher Lademacher, William Hope, Michael Neely, Peter Bonate i Andrea Edginton. "1396. Predictions of Isavuconazonium Sulfate Dosage in Patients Aged 6 Months: <18 Years by Physiologically Based Pharmacokinetic Modeling". Open Forum Infectious Diseases 5, suppl_1 (listopad 2018): S429—S430. http://dx.doi.org/10.1093/ofid/ofy210.1227.
Pełny tekst źródłaZhou, Kaixiang, Meixia Huo, Wenjin Ma, Kun Mi, Xiangyue Xu, Samah Attia Algharib, Shuyu Xie i Lingli Huang. "Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion". Pharmaceutics 13, nr 5 (22.04.2021): 602. http://dx.doi.org/10.3390/pharmaceutics13050602.
Pełny tekst źródłaMian, P., K. Allegaert, S. Conings, P. Annaert, D. Tibboel, M. Pfister, K. van Calsteren, JN van den Anker i A. Dallmann. "P66 Characterization of the pharmacokinetics of acetaminophen and its metabolites in the fetus through integration of placental transfer in a physiologically based pharmacokinetic model". Archives of Disease in Childhood 104, nr 6 (17.05.2019): e44.2-e45. http://dx.doi.org/10.1136/archdischild-2019-esdppp.104.
Pełny tekst źródłaLi, Yuezhe, A. Katharina Wilkins, Tim Knab i Joseph P. Boni. "Abstract 875: Quantitative systems pharmacology modeling of loncastuximab tesirine combined with mosunetuzumab and glofitamab helps guide dosing for patients with DLBCL". Cancer Research 84, nr 6_Supplement (22.03.2024): 875. http://dx.doi.org/10.1158/1538-7445.am2024-875.
Pełny tekst źródłaTürk, Denise, Nina Hanke i Thorsten Lehr. "A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug–Drug–Gene Interaction Predictions". Pharmaceutics 12, nr 11 (10.11.2020): 1074. http://dx.doi.org/10.3390/pharmaceutics12111074.
Pełny tekst źródłaMarok, Fatima Zahra, Jan-Georg Wojtyniak, Laura Maria Fuhr, Dominik Selzer, Matthias Schwab, Johanna Weiss, Walter Emil Haefeli i Thorsten Lehr. "A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators". Pharmaceutics 15, nr 2 (17.02.2023): 679. http://dx.doi.org/10.3390/pharmaceutics15020679.
Pełny tekst źródłaPepin, Xavier J. H., Natalie J. Sanderson, Alexander Blanazs, Shveta Grover, Timothy G. Ingallinera i James C. Mann. "Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model input". European Journal of Pharmaceutics and Biopharmaceutics 142 (wrzesień 2019): 421–34. http://dx.doi.org/10.1016/j.ejpb.2019.07.014.
Pełny tekst źródłaFenneteau, F., J. Li, L. Couture, J. Turgeon i F. Nekka. "Prediction of the disposition of a P-gp substrate in wild-type and knockout mice tissues: Development of a physiologically based pharmacokinetic (PBPK) model and its global sensitivity analysis". PAMM 7, nr 1 (grudzień 2007): 1121905–6. http://dx.doi.org/10.1002/pamm.200700608.
Pełny tekst źródłaXie, Yuewu, Huixiang Liu, Xiaoyue Chen i Jie Xing. "The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model". Current Drug Metabolism 22, nr 5 (15.07.2021): 363–71. http://dx.doi.org/10.2174/1389200222666210129102411.
Pełny tekst źródładel Río, A., C. García-de-la-Mària, J. M. Entenza, O. Gasch, Y. Armero, D. Soy, C. A. Mestres i in. "Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus". Antimicrobial Agents and Chemotherapy 60, nr 1 (2.11.2015): 478–86. http://dx.doi.org/10.1128/aac.02139-15.
Pełny tekst źródłaDennison, James E., Philip L. Bigelow i Melvin E. Andersen. "Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose". Toxicology and Industrial Health 20, nr 6-10 (lipiec 2004): 165–75. http://dx.doi.org/10.1191/0748233704th203oa.
Pełny tekst źródłaHu, Jing, Zhengbao Zhang, Senwei Lin, Qiuhuan Zhang, Guoxia Du, Ruishan Zhou, Xiaohan Qu, Guojiang Xu, Ying Yang i Yongming Cai. "Application of All-Ages Lead Model Based on Monte Carlo Simulation of Preschool Children’s Exposure to Lead in Guangdong Province, China". Sustainability 15, nr 2 (6.01.2023): 1068. http://dx.doi.org/10.3390/su15021068.
Pełny tekst źródłaIbrahim, A. H., H. Barry i C. M. Hughes. "A cross-sectional survey of general practitioners’ experiences with, views of, and attitudes towards, practice-based pharmacists". International Journal of Pharmacy Practice 29, Supplement_1 (26.03.2021): i24—i25. http://dx.doi.org/10.1093/ijpp/riab015.029.
Pełny tekst źródłaJayawardena, Thilina U., Lei Wang, K. K. Asanka Sanjeewa, Sang In Kang, Jung-Suck Lee i You-Jin Jeon. "Antioxidant Potential of Sulfated Polysaccharides from Padina boryana; Protective Effect against Oxidative Stress in In Vitro and In Vivo Zebrafish Model". Marine Drugs 18, nr 4 (14.04.2020): 212. http://dx.doi.org/10.3390/md18040212.
Pełny tekst źródłaAudi, Said H., Anthony Cammarata, Anne V. Clough, Ranjan K. Dash i Elizabeth R. Jacobs. "Quantification of mitochondrial membrane potential in the isolated rat lung using rhodamine 6G". Journal of Applied Physiology 128, nr 4 (1.04.2020): 892–906. http://dx.doi.org/10.1152/japplphysiol.00789.2019.
Pełny tekst źródłaTudora, Anabella, i Franz-Josef Hambsch. "Parameterisation of the residual temperature distribution based on the modelling of successive emission of prompt neutrons". EPJ Web of Conferences 169 (2018): 00025. http://dx.doi.org/10.1051/epjconf/201816900025.
Pełny tekst źródłaShea, T. C., J. R. Mason, A. M. Storniolo, B. Newton, M. Breslin, M. Mullen, D. M. Ward, L. Miller, M. Christian i R. Taetle. "Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy." Journal of Clinical Oncology 10, nr 3 (marzec 1992): 464–73. http://dx.doi.org/10.1200/jco.1992.10.3.464.
Pełny tekst źródłaKallidaikurichi Srinivasan, Karthikeyan, Anthony Gallagher, Niall O’Brien, Vinod Sudir, Nick Barrett, Raymund O’Connor, Francesca Holt, Peter Lee, Brian O’Donnell i George Shorten. "Proficiency-based progression training: an ‘end to end’ model for decreasing error applied to achievement of effective epidural analgesia during labour: a randomised control study". BMJ Open 8, nr 10 (październik 2018): e020099. http://dx.doi.org/10.1136/bmjopen-2017-020099.
Pełny tekst źródłaHanke, Nina, Sebastian Frechen, Daniel Moj, Hannah Britz, Thomas Eissing, Thomas Wendl i Thorsten Lehr. "PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin". CPT: Pharmacometrics & Systems Pharmacology 7, nr 10 (7.09.2018): 647–59. http://dx.doi.org/10.1002/psp4.12343.
Pełny tekst źródłaZubair, Abba, Rhonda Grant, Han Tun, Candido Rivera, Alvaro Moreno-aspitia, Vivek Roy, Gerry Colon-Otero i Lawrence Solberg. "Platelet Count Is a Sensitive Predictor of Bone Marrow Reserve and Autologous Peripheral Blood Progenitor Cell Mobilization." Blood 106, nr 11 (16.11.2005): 5280. http://dx.doi.org/10.1182/blood.v106.11.5280.5280.
Pełny tekst źródłaLiu, Xingbang, i Yong He. "Effect and Clinical Value of Protective Motivation Intervention Rehabilitation Model on Pain Perception and Dysfunction in Patients with Lumbar Disc Herniation: Based on a Retrospective Cohort Study". Computational and Mathematical Methods in Medicine 2022 (30.08.2022): 1–8. http://dx.doi.org/10.1155/2022/5911889.
Pełny tekst źródłaWeaver, CH, B. Hazelton, R. Birch, P. Palmer, C. Allen, L. Schwartzberg i W. West. "An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy". Blood 86, nr 10 (15.11.1995): 3961–69. http://dx.doi.org/10.1182/blood.v86.10.3961.bloodjournal86103961.
Pełny tekst źródłaGlass, Bertram, Lutz Uharek, Matthias Zeis, Peter Dreger, Helmut Löffler, Jörg Steinmann i Norbert Schmitz. "Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect". Blood 90, nr 4 (15.08.1997): 1694–700. http://dx.doi.org/10.1182/blood.v90.4.1694.
Pełny tekst źródłaGlass, Bertram, Lutz Uharek, Matthias Zeis, Peter Dreger, Helmut Löffler, Jörg Steinmann i Norbert Schmitz. "Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect". Blood 90, nr 4 (15.08.1997): 1694–700. http://dx.doi.org/10.1182/blood.v90.4.1694.1694_1694_1700.
Pełny tekst źródłaSchiedlmeier, B., K. Kühlcke, H. G. Eckert, C. Baum, W. J. Zeller i S. Fruehauf. "Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice". Blood 95, nr 4 (15.02.2000): 1237–48. http://dx.doi.org/10.1182/blood.v95.4.1237.
Pełny tekst źródłaGubanova, M. V., N. N. Kushnarenko i T. M. Karavaeva. "Clinical significance of 24-hour blood pressure monitoring in prediction of hypertension development in patients with gout". Siberian Journal of Clinical and Experimental Medicine 36, nr 3 (7.10.2021): 104–10. http://dx.doi.org/10.29001/2073-8552-2021-36-3-104-110.
Pełny tekst źródłaSeeger, Timon, Marlon Veldwijk, Gary Bridger, Gary Calandra, Hartmut Goldschmidt, Anthony Ho i Stefan Fruehauf. "The CXCR4 Antagonist AMD3100 Mobilizes a More Primitive Subset of CD34+ Cells Than G-CSF." Blood 106, nr 11 (16.11.2005): 1969. http://dx.doi.org/10.1182/blood.v106.11.1969.1969.
Pełny tekst źródłaGoldberg, Joel, Christopher Bethel, Andrea M. Hujer, Steven Marshall, Magdalena A. Taracila, Krisztina M. Papp-Wallce, Vijay Kumar, Focco van den Akker, Mark Plummer i Robert A. Bonomo. "1256. In Vivo Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and Acinetobacter spp". Open Forum Infectious Diseases 7, Supplement_1 (1.10.2020): S645. http://dx.doi.org/10.1093/ofid/ofaa439.1440.
Pełny tekst źródłaWilmsmeier, Lisa, Jeannine Von Der Born, Rizky I. Sugianto, Carl Grabitz, Bernhard Mw Schmidt, Ana Celine Braun, Denise Homeyer, Uwe Tegtbur i Anette Melk. "SIGNIFICANT INCREASES IN PERIPHERAL AND CENTRAL BLOOD PRESSURE IN CHILDREN AT MUCH LOWER BODY MASS INDEX THAN EXPECTED". Journal of Hypertension 42, Suppl 1 (maj 2024): e11. http://dx.doi.org/10.1097/01.hjh.0001019420.16281.8a.
Pełny tekst źródła